I agree with Fireman 100%. I've seen a small single drug development company try to GIA after spectacular top line data. Everyone was saying the drug should sell itself, basically sales people would be order takers, because the benefit of adding Vascepa on top of statins reduces cardiac events by 25% on top of the 25% when using statins alone. They hired and trained 800 sales people nationally. The company did a large cash raise a buck or two below the PPS. Buy the rumor sell the news was a common occurrence. There were Television spots, Super Bowl adds, and at the end of the day, they hit a wall at 65,000 scripts a week. Week after week, it was like watching a stuck gauge. Yet, when TLD was presented at the AHA in a room full of 2000 cardiologists, it was said that the entire room stood up to applaud the lead investigator, who has published 750 papers, Dr. Deepak Bhatt.
NWBO is an office with 30 people, which includes 4 C level execs? You can't just flip the switch and become a markeing machine. JMHO
ILT